
The autoantigen p90 is a recently discovered protein that binds to and inhibits Protein Phosphatase 2A (PP2A) activity, thereby playing a critical role in cancer progression. Thus, p90 was renamed the "cancerous inhibitory protein of PP2A" or CIP2A. Most interestingly CIP2A was shown to inhibit of the degradation of c-Myc oncoprotein and was reported to be overexpressed in several cancers (1). However, the clinical relevance of CIP2A to human cancers had not been demonstrated, and the mechanism of its regulation and its clinical role in cancer are unknown. A recent study evaluated tissue microarrays consisting of 223 gastric...




-Western-Blot-NBP1-97512-img0001.jpg)
-Western%20Blot-NB600-907-img0001.jpg)
